Clinical Trial

AI to Create Accessible & Reliable Patient Education Materials

Study acronym: AI-CARE
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
This study investigates the use of Generative AI (GAI) to support primary care practices in delivering accurate, accessible patient education. With the rise of health misinformation, increasingly complex patient needs, and a strained healthcare workforce, primary care must find new ways to communicate trusted health information effectively. Leveraging the Canadian Primary Care Information Network (CPIN), this study will generate patient education messages on key health topics using both GAI and human content experts. Diverse review panels of patients and providers will assess the messages on quality of information, adaptability, and relevance and usefulness, with special attention to socioeconomic factors that may impact message accessibility. CPIN will recruit a diverse sample of participants to evaluate both GAI- and human-generated messages. Review panels will provide structured feedback via surveys, aiming to identify differences in content quality and effectiveness. The study's goal is to determine whether GAI can produce high-quality health information that meets primary care standards. Results will reveal how GAI tools can support primary care in reducing misinformation and administrative burdens, fostering patient-provider relationships, and improving health equity. Findings will inform best practices for integrating GAI in primary care to ensure accessible, timely patient education across Canada.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-21.
Trial Details
NCT Number NCT06997107
Lead Sponsor Hopital Montfort
Collaborators: Cheo Research Institute, Eastern Ontario Health Unit
Conditions Primary Care Patients
Enrollment 50 participants
Start Date 2025-01-16
Primary Completion 2026-04 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-06-04